Compare · BIOX vs SNES
BIOX vs SNES
Side-by-side comparison of Bioceres Crop Solutions Corp. (BIOX) and SenesTech Inc. (SNES): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOX and SNES operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- BIOX is the larger of the two at $502.3M, about 61.9x SNES ($8.1M).
- Over the past year, BIOX is down 90.8% and SNES is down 46.7% - SNES leads by 44.2 points.
- SNES has been more active in the news (10 items in the past 4 weeks vs 7 for BIOX).
- BIOX has more recent analyst coverage (7 ratings vs 0 for SNES).
- Company
- Bioceres Crop Solutions Corp.
- SenesTech Inc.
- Price
- $0.46-1.60%
- $1.53-6.13%
- Market cap
- $502.3M
- $8.1M
- 1M return
- -5.69%
- +6.99%
- 1Y return
- -90.85%
- -46.69%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- AMEX
- NASDAQ
- IPO
- 2016
- News (4w)
- 7
- 10
- Recent ratings
- 7
- 0
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It operates in Argentina, Austria, Bolivia, Brazil, Lebanon, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
SenesTech Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Latest BIOX
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- SEC Form 3 filed by new insider Duraiswami Narain
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- Amendment: SEC Form 3 filed by new insider Simmermacher Ezequiel
- New insider Mago Yogesh claimed ownership of 55,399 units of Ordinary Shares (SEC Form 3)
- Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results
- New insider Trucco Federico claimed ownership of 356,000 units of Ordinary Shares (SEC Form 3)
- CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
- Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
- SEC Form 3 filed by new insider Roque Jose Augusto
Latest SNES
- SEC Form DEFA14A filed by SenesTech Inc.
- SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda
- SEC Form DEFA14A filed by SenesTech Inc.
- SenesTech Announces Amendment to Equity Incentive Plan Proposal
- SEC Form DEFA14A filed by SenesTech Inc.
- SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
- Large owner Glenbrook Capital Management bought $53,486 worth of shares (32,120 units at $1.67) (SEC Form 4)
- Chief Executive Officer Edell Michael bought $5,013 worth of shares (3,000 units at $1.67) (SEC Form 4)
- SenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition